Core Wealth Partners’s Gilead Sciences GILD Stock Holding History

Core Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Buy	18,313 +270	+1%	+$35.6K	0.99%	27
2026 Q1	$2.51M	Sell	18,043 -955	-5%	-$134K	1.17%	23
2025 Q4	$2.33M	Buy	18,998 +177	+0.9%	+$21.5K	1.05%	29
2025 Q3	$2.09M	Buy	18,821 +100	+0.5%	+$11.4K	0.96%	32
2025 Q2	$2.08M	Buy	18,721 +242	+1%	+$25.8K	1.05%	26
2025 Q1	$2.07M	Buy	18,479 +156	+0.9%	+$16.1K	1.2%	20
2024 Q4	$1.69M	Buy	18,323 +159	+0.9%	+$14.3K	0.97%	25
2024 Q3	$1.52M	Hold	18,164	–	–	0.92%	25
2024 Q2	$1.25M	Buy	+18,164	New	+$1.21M	0.85%	29

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Core Wealth Partners's GILD Position: Q2 2026 in Review

Core Wealth Partners increased its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, buying an estimated $35.6K and bringing the position to 18,313 shares worth $2.31M. The position accounts for 0.99% of the portfolio, ranked #27.

Core Wealth Partners first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.51M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Core Wealth Partners held 18,313 shares of Gilead Sciences worth $2.31M as of Q2 2026.
Core Wealth Partners bought 270 Gilead Sciences shares in Q2 2026, an estimated $35.6K.
Gilead Sciences made up 0.99% of Core Wealth Partners's portfolio in Q2 2026, its #27 holding.
Core Wealth Partners first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Core Wealth Partners's Gilead Sciences position peaked at $2.51M in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.